A number of studies in dairy cows have shown a relationship between milk fat depression (MFD) and alterations caused in lipogenic gene expression by dietary nutrients.
Interpretive summary
Fish oil-induced milk fat depression and associated downregulation of mammary lipogenic genes in dairy ewes (by Carreño et al.) Information about the relationship between milk fat depression (MFD) and alterations caused in lipogenic gene expression by dietary nutrients is not only scarce, but also inconsistent in small ruminants. Dietary fish oil was used as a mean of experimentally inducing MFD in sheep to study the effects on milk fatty acid composition and mRNA abundance of key candidate genes involved in mammary lipogenesis. Increases in putative milk fat inhibitors were accompanied by decreases in transcript abundances, supporting an association between them and suggesting that FO-induced MFD in dairy ewes would be mediated by downregulation of lipogenic genes.
FISH OIL DOWNREGULATES LIPOGENIC GENES IN EWES
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INTRODUCTION
Without ruling out the potential involvement of other causative factors, it is widely accepted that the low-milk fat syndrome is mediated by alterations of ruminal fermentation resulting in the formation of specific bioactive fatty acids (FA) that will exert antilipogenic effects in the mammary gland (Bauman and Griinari, 2001; Shingfield et al., 2010) . However, the molecular mechanisms by which these FA are able to decrease mammary synthesis of fat remain uncertain (Bauman et al., 2011) . Based on studies in dairy cows, the low-milk fat syndrome, commonly referred to as milk fat depression (MFD), has been hypothesized to be caused by alterations in lipogenic gene expression by dietary nutrients (Harvatine and Bauman, 2006; Angulo et al., 2012; Bionaz et al., 2015) . The downregulation of the mRNA abundance of key genes involved in milk fat synthesis by trans-10 cis-12 CLA is likely the best-known example of nutrigenomics in this area (Shingfield et al., 2010; Bauman et al., 2011; Hussein et al., 2013) .
Nevertheless, information about nutrigenomics and lipid metabolism in small ruminants is not only scarce but also inconsistent (Shingfield et al., 2013) . For example, Hussein et al. (2013) reported that trans-10 cis-12 CLA-induced MFD in lactating ewes involves the SREBF family and a coordinated downregulation of genes related to mammary lipid synthesis (e.g., ACACA, FASN, SCD1, AGPAT6, SREBF1 or INSIG1). In contrast, several studies in dairy sheep (Dervishi et al., 2012; Bichi et al., 2013a; Castro-Carrera et al., 2015) or dairy goats (Bernard et al., 2008; Tsiplakou et al., 2009; Toral et al., 2013 ) observed a weak relationship between changes in milk FA production and mammary mRNA abundance of key candidate genes and transcription factors involved in lipid metabolism. Yet, Bichi et al. (2013a) , who studied that relationship after 54 days on marine lipids, suggested that transcriptional regulation in dairy ewes might have been established earlier during the feeding period. This speculation was based on Invernizzi et al. (2010) 's findings in mammary tissue from dairy cows fed saturated lipids or soybean oil and fish oil: they observed that transcriptional control mechanisms altering the expression of several lipogenic genes (e.g., PPARG, LPIN1, SREBF1, ACSS2, ACACA, FASN or LPL) were affected by day 7 post-feeding, but variations between diets had disappeared on day 21.
This experiment was therefore conducted in dairy ewes to study the effect of dietary supplementation with marine lipids, which is known to induce MFD in this species (Capper et al., 2007; Bichi et al., 2013b; Toral et al., 2016b) , on milk fat composition and mRNA abundance of key candidate genes involved in mammary lipogenesis. Based on previous reports (Invernizzi et al., 2010; Toral et al., 2010; Bichi et al., 2013a) , we hypothesized that changes in FA composition and gene expression would be detected early during the feeding period whereas the milk fat decrease would only be observed latter on. To test this hypothesis, transcript and FA profiles were examined before starting the assay and after 1 and 4.5 weeks on a control or a fish oil supplemented diet.
MATERIALS AND METHODS

Animals, Experimental Diets and Management
All experimental procedures were approved and completed in accordance with the Spanish Royal Decree 53/2013 for the protection of animals used for experimental purposes.
Twelve lactating Assaf ewes (BW = 77.8 kg, SD = 7.81; DIM = 63, SD = 7.8; milk production = 2.5 kg/d, SD = 0.35) were housed in individual tie stalls and randomly allocated to one of 2 groups (n = 6). They were used to test the effects of 2 dietary treatments consisting of a TMR, based on alfalfa hay (particle size > 4 cm) and concentrates (50:50), without lipid supplementation (control) or supplemented with 17 g of fish oil (Afampes 121 DHA; Afamsa, Mos, Spain)/kg of diet DM (FO). The ingredients and chemical composition of the experimental diets, which were prepared weekly and included molasses to reduce selection of and the incision was closed with suture clips and sprayed with topical antibiotic (oxytetracycline) and a wound-healing product (micronized aluminium powder). Ewes also received injections of antibiotic (amoxicillin and colistin), anti-inflammatory (ketoprofen) and systemic hemostatic drugs (ethamsylate) . No incidences of mastitis were detected for any ewe in the study.
Laboratory Analysis
Diets. Samples were analyzed for DM (ISO, 1999a ), ash (ISO, 2002 , and CP (ISO, 2009 ). The NDF and ADF were determined using an Ankom 2000 fiber analyzer (Ankom Technology Methods 13 and 12, respectively; Ankom Technology Corp., Macedon, NY); the former was assayed with sodium sulfite and α-amylase, and both were expressed with residual ash. Fatty acid methyl esters of lipid in freeze-dried samples of TMR were prepared in a 1-step extraction-transesterification procedure using chloroform (Sukhija and Palmquist, 1988) and 2% (vol/vol) sulfuric acid in methanol (Shingfield et al., 2003) , and cis-12 tridecenoate (Larodan, Solna, Sweden) as an internal standard. Methyl esters were separated and quantified using a gas chromatograph (Agilent 7890A GC System, Agilent Technologies Inc., Santa Clara, CA) equipped with a flame-ionization detector and a 100-m fused silica capillary column (0.25 mm i.d., 0.2-μm film thickness; CP-SIL 88, CP7489, Varian Ibérica S.A., Madrid, Spain) and hydrogen as the carrier gas (207 kPa, 2.1 mL/min). The total FAME profile in a 2-μL sample volume at a split ratio of 1:50 was determined using a temperature gradient program (Shingfield et al., 2003) . Peaks were identified based on retention time comparisons with commercially available standard FAME mixtures (Nu-Chek Prep., Elysian, MN; and Sigma-Aldrich, Madrid, Spain).
Milk. Fat and CP concentrations were determined by infrared spectrophotometry (ISO, 1999b) using a MilkoScan FT6000 (Foss, Hillerød, Denmark). Lipid in 1 mL of milk was extracted using diethylether and hexane (5:4, vol/vol) and transesterified to FAME using freshly prepared methanolic sodium methoxide as a catalyst (Shingfield et al., 2003) . The total FAME profile was determined by gas chromatography using the same chromatograph and temperature gradient program applied for the analysis of feeds, but isomers of 18:1 were further resolved in a separate analysis under isothermal conditions at 170ºC (Shingfield et al., 2003) . Peaks were identified based on retention time comparisons with the same FAME mixtures used for the analysis of feeds, other commercially available standards (Nu-Chek Prep.; Sigma-Aldrich; and Larodan), cross referencing with chromatograms reported in the literature (Shingfield et al., 2003; Halmemies-Beauchet-Filleau et al., 2011) and comparison with reference samples for which the FA composition was determined based on gas chromatography analysis of FAME and GC-MS analysis of corresponding 4,4-dimethyloxazoline derivatives (Bichi et al., 2013b) .
Mammary tissue. RNA Isolation and Quantitative PCR. Total RNA from the mammary secretory tissue was isolated and purified (PureLink RNA Mini kit, Invitrogen, Carlsbad, CA) as described in Bonnet et al. (2013) , with the exception that the tissue was homogenized using a bead beater (Mini-bead Beater-8, BioSpec Products, Bartlesville, OK).
The concentration and purity of RNA was determined by spectrophotometry using a NanoDrop ND-1000 spectrophotometer (Nano-Drop Technologies, Wilmington, DE), and the RNA integrity by capillary electrophoresis (Agilent 2100 Bioanalyzer, Agilent Technologies Inc.). The average RNA integrity number (RIN) of the samples was 8.1 ± 0.46. For quantitative PCR (qPCR) analysis, cDNA was synthesized using the High Capacity RNA-tocDNA kit (Applied Biosystems, Foster City, CA) and the lack of DNA contamination was verified by a PCR amplification using ACTB primers flanking an intron (Supplementary Table   S1 ). The qPCR was carried out (Bonnet et al., 2013 ) using a 7500 Real-Time PCR System (Applied Biosystems) and specific primers for the main candidate genes and transcription factors involved in mammary lipogenesis. These genes are described in Table 2 and were selected on the basis of previous works on lipid metabolism in ruminants (e.g., Bernard et al., 2008; Bauman et al., 2011; Ma and Corl, 2012) . To account for variations in RNA integrity and quantification and cDNA synthesis, mRNA abundance was normalized using the geometric mean of 3 reference genes (Table 2) , which have been identified as suitable internal controls (Bionaz and Loor, 2007; Bonnet et al., 2013) and were confirmed as the most stable genes among those quantified using the geNorm procedure (Vandesompele et al., 2002) . The primer sequences and qPCR performance are shown in Supplementary Tables S1 and S2, respectively. The abundance of gene transcripts was expressed as the log2 value of mRNA copy number relative to the geometric mean of the 3 reference genes.
Statistical Analysis
All statistical analyses were performed using the SAS software package (version 9.4; SAS Institute Inc., Cary, NC). After the second biopsies, two animals from each group were removed from the assay because they showed a slow recovery. Animal performance, milk FA composition and mammary mRNA abundances of candidate genes (log2 transformed values)
were analyzed for repeated measures using PROC MIXED. For each variable, the covariance structure (e.g., compound symmetric, first-order autoregressive, heterogeneous first-order autoregressive, first-order antedependence or unstructured) was selected on the basis of + FO-d8 for mammary mRNA abundance data) was used to test that the effect of FO supplementation was not detected early (days 7-8) but late (days 30-31) during the feeding period. Differences were declared significant at P < 0.05 and considered a trend toward significance at P < 0.10, and least squares means (adjusted for the covariance) are reported throughout.
RESULTS
Animal Performance and Milk Composition
Fish oil supplementation had no effect on DMI and milk yield, but significantly modified milk composition (Table 3) . Compared with the control, reductions in milk fat concentration and yield were not detected on day 7, but reached up to 25 and 22%, respectively, on day 30. The milk protein content also tended to be decreased by FO, but to a lower extent (−6%) and on both sampling days. Time exerted a negative effect on milk yield.
Milk FA Composition
Addition of fish oil to the diet had a marked influence on milk FA composition (Table   4 and Supplementary Table S3 ). Variations in relative proportions of FA derived from mammary uptake were generally more relevant than those observed in de novo synthesized FA, and most changes were already detected on day 7 and comparable on both sampling days.
For example, concentrations of the antilipogenic trans-10 cis-12 CLA and other trans 18:2 intermediate metabolites, such as trans-9 cis-12 and trans-11 cis-15 18:2, or cis-9 trans-11, trans-11 cis-13 and trans,trans CLA, were increased several times compared with the control.
These increases were similar on days 7 and 30. On the contrary, the large increment in trans-9 cis-11 CLA was greater at the end of the trial, in coincidence with a rise in trans-10 18:1 and a less pronounced increase in trans-11 18:1.
Notable variations in milk long-chain FA also included reductions in the major C18
FA, namely 18:0 and cis-9 18:1, which averaged 69 and 41%, respectively, as well as an increase in oxo-FA, which tended to be greater on day 30, and in cis-11 18:1. Similarly, the proportions of very long-chain n-3 PUFA (i.e., 20:5n-3, 22:5n-3 and 22:6n-3) were augmented with this treatment, whereas the milk concentration of major PUFA in the control (namely, 18:2n-6 and 18:3n-3) was negatively affected by oil supplementation. The percentage of some short-and medium-chain FA in milk was also modified by the FO diet, with decreases in 4:0, cis-9 12:1, 14:0 and cis-9 14:1, and increases in 8:0, cis-9 16:1 and trans-9 16:1 that were comparable in both sampling days. However, the concentration of milk 10:0 was increased in the early stage of the treatment (d 7), and that of 6:0 tended to be higher at the end point (d 30).
On a molar basis, FA with less than 16 carbons accounted for 43% of the reduction in milk fat yield with FO on day 30, and those with 18 or more carbon atoms for 27%, whereas the other 30% was explained by C16 FA (data not shown in Tables) .
mRNA Abundance of Candidate Genes
As shown in Table 5 , the mRNA abundance of most candidate genes was affected by either diet or time. The lipogenic genes ACACA, ACSS2 and AGPAT6, and the transcription factor SREBF1 were downregulated in the mammary tissue of ewes fed FO. Also the abundance of FABP3, LPL, SCD1 and INSIG1 transcripts tended to be reduced by marine lipid supplementation. All these changes in gene expression were already identified on day 8
and remained stable afterwards, whereas those of FASN were only detected on day 31. With regard to the effect of time on candidate gene expression, greater mRNA abundances of PPARG1 and THRSP were found on day 31 compared with day 8, and the opposite behavior was observed for ACSS2, DGAT1, GPAM, LPIN1, SCAP and SREBF1.
DISCUSSION
Dietary supplementation of dairy ewes with marine lipids is known to modulate milk FA composition towards a potentially healthier profile for consumers (Capper et al., 2007; Bichi et al., 2013b; Toral et al., 2016b) . However, it induces MFD, which has a negative effect on ovine cheese making and hampers the implementation of this feeding strategy.
Because the causative factors and mechanisms involved in this syndrome are still uncertain, like in dairy cows, MFD remains an active area of research (Hussein et al., 2013; Bionaz et al., 2015; Toral et al., 2015a) .
In the present study, fish oil was used as a mean of experimentally decreasing milk fat concentration and yield in sheep, based on earlier reports indicating that this species is not prone to develop MFD with plant oils (Mele et al., 2006; Pulina et al., 2006; Castro-Carrera et al., 2015) . This is probably the first but not the only difference when comparing this syndrome in ovine and bovine. As expected, feeding FO caused MFD, with a reduction in milk fat content (25% on day 30) that was within the range observed in lactating sheep consuming marine lipids (17-31%; Capper et al., 2007; Toral et al., 2010; Bichi et al., 2013b) .
The MFD syndrome has been defined in dairy cows as a reduction in milk fat synthesis with no change in the yield of milk and other components (Bauman et al., 2011) . In dairy ewes, however, MFD is often accompanied by small decreases in milk protein concentration (approx. 5-7%; Toral et al., 2010 Toral et al., , 2016b , which is consistent with our results. Mechanisms involved in milk protein depression might be speculated to be independent from those underlying the inhibition in lipogenesis, because reductions in protein content also occur in the absence of changes in milk fat synthesis when sheep receive lipid supplements (e.g., Mele et al., 2006; Pulina et al., 2006) . This is in agreement with our observations on day 7, when MFD had not been detected yet.
Another difference between dairy cows and sheep is that several nutritional assays in cows have shown a relationship between marine lipid-induced MFD and changes in mammary gene expression (e.g., Ahnadi et al., 2002; Harvatine and Bauman, 2006; Angulo et al., 2012) , whereas this link is not so clear in ewes. For instance, Bichi et al. (2013a) could not detect any significant relationship between the MFD observed in dairy sheep after 54 days of diet supplementation with microalgae and the mRNA abundance of the studied lipogenic genes. However, concurring with our results and based on findings by Invernizzi et al. (2010) , the authors suggested that transcriptional regulation mechanisms could be established early during the feeding period.
In line with this, we observed higher contents of trans-10 cis-12 and trans-9 cis-11
18:2, two CLA isomers with confirmed or putative, respectively, antilipogenic properties after only 7 days on FO. Yet, these increments were lower than those reported to affect milk fat synthesis when administered separately (Perfield et al., 2007; Shingfield et al., 2010; Hussein et al., 2013) . This contributes to its actual involvement in FO-induced MFD remaining uncertain and supports that other less well-known inhibitor FA might play a relevant role in the low-milk fat syndrome. In this regard, our results agree with recent reports that suggest a potential influence of cis-9 16:1, cis-11 18:1, and oxo-FA (Kairenius et al., 2015; Toral et al., 2015a Toral et al., , 2016b Kadegowda et al., 2009; Hussein et al., 2013) and suggests that FO-induced MFD in dairy ewes would be mediated by downregulation of lipogenic genes. This mechanism, previously observed in other dairy ruminants (Shingfield et al., 2010; Bauman et al., 2011; Bionaz et al., 2015) , would have tended to affect most studied metabolic pathways, including FA activation (ACSS2), de novo synthesis (ACACA and FASN), uptake and transport (LPL and FABP3), desaturation (SCD1) and esterification (AGAPT6).
The enzyme encoded by ACACA has been traditionally considered as responsible for the rate-limiting step in de novo lipogenesis (Bauman and Davis, 1974) Following the pathways of milk fat synthesis in the mammary epithelial cell, prior to the synthesis of milk triacylglycerols, some FA can be subjected to the action of Δ 9 -desaturase, an enzyme that deserves particular attention due to its key role in milk fat composition Toral et al., 2015b) . The nutritional regulation of SCD1 gene expression involves complex interactions between dietary factors and regulatory events that have not been well characterized yet . Still, consistent with our results, a number of studies have shown a downregulation of SCD1 during MFD induced by marine and plant lipid supplementation (Ahnadi et al., 2002; Peterson et al., 2003; Angulo et al., 2012) or CLA administration (Baumgard et al., 2002; Gervais et al., 2009 ), the latter not only in cows but also in dairy ewes (Hussein et al., 2013) . Increases in 20:5n-3 and trans-10 cis-12 CLA, which were observed from the early stage of FO treatment, might have been involved in this inhibition (Kadegowda et al., 2009; Bernard et al., 2013) .
Due to the diet-induced differences in the availability of cis-9-containing FA and substrates for mammary Δ 9 -desaturation, it was not possible to associate the tendency to a downregulation of SCD1 with systematic reductions in its product milk concentrations.
However, the inhibition might have contributed to a further decline in the already low cis-9
18:1 milk content derived from the shortage of 18:0 of ruminal origin (Shingfield et al., 2003; Toral et al., 2016b) . Decreases in these FA have been linked to altered milk fat fluidity and tentatively to the negative impact of marine lipids on mammary lipogenesis (Gama et al., 2008; Shingfield et al., 2010; Bichi et al., 2013b) , although some recent results in dairy ewes (Toral et al., 2016b ) question its relevance. In any event, it is probably worth mentioning that Bionaz and Loor (2008) speculated that FABP3 would provide 18:0 to the SCD, which would worsen the situation in our study.
The last steps of milk fat synthesis include esterification of FA to glycerol and secretion of milk fat globules. Among the studied candidate genes (i.e., GPAM, AGPAT, DGAT1, LPIN1 and XDH), the lack of variation in DGAT1 transcript abundance during MFD (Invernizzi et al., 2010; Bichi et al., 2013a; Hussein et al., 2013) agrees with our findings and is probably explained by its known post-transcriptional regulation (Bernard et al., 2008) .
Conversely, the reduction in AGPAT6 mRNA abundance with FO, in line with previous reports (Baumgard et al., 2002; Peterson et al., 2003; Hussein et al., 2013) , would suggest a greater relevance of transcriptional regulating mechanisms. Based on our results and on inconsistent changes detected in response to diet-induced MFD (Peterson et al., 2003; Invernizzi et al., 2010; Hussein et al., 2013) , this link appears less clear for GPAM, LPIN1
and XDH. Reasons for the specific downregulation of AGPAT6 in ewes fed FO are not clear but its greater affinity for short-and medium-chain saturated FA (Bernard et al., 2008) leaves room for speculation about a relationship with the inhibition of de novo lipogenesis.
Overall, the coordinated nature in all these lipogenic gene changes support the involvement of a central regulator of milk fat synthesis (Bernard et al., 2008; Shingfield et al., 2010; Bauman et al., 2011) . The SREBF1 and PPARG transcription factors seem to play a prominent nutrigenomic role through different mechanisms (Bionaz et al., 2015) . Thus, PPARG-mediated effects in gene expression does not necessarily involve variations in its mRNA abundance (Kadegowda et al., 2009; Shi et al., 2013) , whereas downregulation of SREBF1 is frequently detected during MFD induced by CLA (Gervais et al., 2009; Hussein et al., 2013) or marine lipid supplementation (Harvatine and Bauman, 2006; Invernizzi et al., 2010; Angulo et al., 2012) , as observed in our study. Furthermore, there may be complex interactions between them: PPARG could partly control the expression of SREBF1, which in turn could affect the activity of PPARG by increasing the production of its natural agonists (Bionaz et al., 2015) .
Other transcription factors, such as INSIG1 and SCAP, are known to be involved in SREBF1 activation to its mature form (the nuclear SREBP1; Sakai et al., 1998; Yang et al., 2002) . So far, no clear association between lipid supplementation and changes in SCAP transcript abundance has been demonstrated, in contrast to diet-induced changes in both INSIG and SREBF1 mRNA abundances during MFD (Harvatine and Bauman, 2006; Mach et al., 2011; Hussein et al., 2013) , which concurs with our observations. Reduced SREBF1 transcript abundance in ewes fed FO may be indicative of an inhibition of SREBP1 signaling pathway and of its target genes (Bernard et al., 2008; Ma and Corl, 2012) , which could contribute to explain the negative effects of FO on the expression of a large number of our candidate genes, including ACACA, FASN, LPL, FABP3 and SCD1.
Concerning THRSP, although there is evidence indicating that this gene acts as a relevant transcriptional regulator in the mammary responses to antilipogenic FA in bovine (Bauman et al., 2011) , neither our results nor the little available information in dairy ewes (Bichi et al., 2013a; Hussein et al., 2013) allow to confirm a similar role in this species.
Further research is necessary to elucidate whether observed differences are attributable to interspecies features in the transcriptional regulation of mammary lipogenic genes or in the ruminal metabolism of PUFA (Shingfield et al., 2010; Toral et al., 2016a) .
Finally, it is probably worth mentioning that our results do not allow to conclude a causative relationship between downregulation and lower milk fat synthesis. In fact, some of the enzymes encoded by the candidate genes that we studied might be no longer necessary during MFD, or not as much, and therefore their inhibition might be a consequence of rather than a cause for the low-milk fat syndrome. This would also merit further investigation.
CONCLUSIONS
Reductions in milk fat concentration and yield in dairy ewes consuming 1.7% DM of fish oil were not detected on day 7 but reached up to 25 and 22%, respectively, after 30 days on the diet. However, increases in potentially antilipogenic FA in milk already appeared on the early stage of treatment and lasted until the end of the feeding period. These increments were accompanied by decreases in the mRNA abundance of candidate genes encoding key lipogenic enzymes, which supports a relationship between them and suggests that FO-induced milk fat depression in dairy ewes would be mediated by transcriptional mechanisms. The coordinated nature of the downregulation, which tended to affect most studied metabolic 
